American College of Cardiology
Jun 11, 2026, 23:38
Why the New 2026 CKM Syndrome Guideline Changes Everything for Chronic Disease Prevention – American College of Cardiology
American College of Cardiology shared a post on LinkedIn:
“The 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the ‘interrelated condition characterized by the interconnections among metabolic risk factors (including obesity and type 2 diabetes), chronic kidney disease (CKD) and cardiovascular disease.’
The document retires, replaces and expands upon the 2013 Guideline for the Management of Overweight and Obesity in Adults.
Read the full guideline in JACC.”
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 14, 2026, 20:53YoonHwa An: Rusfertide in Polycythemia Vera – From Clinical Benefit to Strategic Value
-
Sep 14, 2026, 20:52Andres Alberto Mercado Pompa: External Validation of Prognostic Risk Scores in Cerebral Venous Thrombosis
-
Sep 14, 2026, 20:50Balaji Kirushnan: Advancing Regional Citrate Anticoagulation in CRRT – From Experience to Implementation
-
Sep 14, 2026, 20:48Valerie Dehondt: Nutritional Anemia Is Associated With Increased Risk of Severe COPD Exacerbations
-
Sep 14, 2026, 20:46Nupur Choudhury: Exploring AI-Based Detection of Anemia Using Eye and Fingernail Images
-
Sep 14, 2026, 20:44Shamee Shastry: Chart Before You Chase – Diagnosing Drug-Induced Hemolytic Anemia
-
Sep 14, 2026, 20:43David Reiner: Blood Tests That Can Reveal Nutrition Clues
-
Sep 14, 2026, 20:40Giuseppe Biondi Zoccai: Balancing Thrombosis and Bleeding in Acute MI With Hemophilia A
-
Sep 14, 2026, 20:39Kemal Karaagac: Kounis Syndrome as a Possible Cause of Very Late Stent Thrombosis